Biopharm Australia

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Biopharm Australia is an Australian pharmaceutical company.


Biopharm Australia Pty Ltd was incorporated in 1980 to develop and market drug treatments for osteoarthritis and allied musculoskeletal disorders in veterinary medicine. Biopharm Australia has developed injectable veterinary pharmaceuticals, Cartrophen Vet and Cartrophen Equine Forte, which produce relief of clinical signs by modifying the causes of the disease.[citation needed]

Biopharm Australia has a good quality assurance testing laboratories that are accredited by the National Association of Testing Authorities, Australia (NATA) and licensed by the Therapeutic Goods Administration (TGA).


Cartrophen vet[edit]

100 mg sodium pentosan polysulfate / mL. Cartrophen Vet is registered for treatment of osteoarthritis in dogs.

Cartrophen equine forte[edit]

250 mg sodium pentosan polysulfate / mL. Cartrophen Equine Forte is registered for the treatment of noninfectious inflammatory joint disease in horses.


External links[edit]

  • Cartrophen ( for Osteoarthritis in dogs and horses)